Skip to main navigation Skip to search Skip to main content

High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia

  • Hao Yuan Lee
  • , Lin Hui Su
  • , Ming Han Tsai
  • , Shin Woo Kim
  • , Hyun Ha Chang
  • , Sook In Jung
  • , Kyung Hwa Park
  • , Jennifer Perera
  • , Celia Carlos
  • , Hock Tan Ban
  • , Gamini Kumarasinghe
  • , Thomas So
  • , Anan Chongthaleong
  • , Po Ren Hsueh
  • , Jien Wei Liu
  • , Jae Hoon Song
  • , Cheng Hsun Chiu
  • Chang Gung University
  • Chang Gung Memorial Hospital
  • Kyungpook National University
  • Chonnam National University
  • University of Colombo
  • Department of Health Manila
  • National University of Singapore
  • Princess Margaret Hospital Hong Kong
  • Chulalongkorn University
  • National Taiwan University
  • Samsung Medical Center, Sungkyunkwan university

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Abstract

This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S. Typhimurium (25.0%) from all countries.

Original languageEnglish
Pages (from-to)2696-2699
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number6
DOIs
StatePublished - Jun 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia'. Together they form a unique fingerprint.

Cite this